Inogen | INGN - Net Income


Inogen reported $-5.96M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Chart Industries USD -145.3M 214.6M Sep/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Orthofix International USD -2.22M 20.57M Dec/2025
Philips EUR 395M 211M Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
Steris USD 192.9M 1000K Dec/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
X T L Biopharmaceuticals USD -255K 298K Dec/2024
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025